No Detail Found!

Frequency of Hyperandrogenism in Females with Polycystic Ovary Syndrome.

Author(s)
Sumera Mehnaz Department of Obstetrics & Gynaecology PAC Hospital Kamra, Pakistan
Rahat Akhtar Department of Obstetrics & Gynaecology, Nishtar Medical University, Multan, Pakistan
Nadia Taj Department of Obstetrics & Gynaecology, Nishtar Medical University, Multan, Pakistan
Abstract
Objective: To find the frequency of Hyperandrogenism and Hirsutism in females with Polycystic Ovary Syndrome. Study Design: Descriptive Case Series. Place and Duration of Study: Department of Gynaecology and Obstetrics Nishtar Hospital Multan from 21th October 2016 to 9th April 2017. Materials and Methods: Eighty polycystic ovary syndrome patients with in reproductive age group (15 - 49 years)18 were included in the study through non probability consecutive sampling technique. Hirsutism was examined by FG scoring system and the assessment of Hyperandrogenism was by measurement of serum testosterone levels. SPSS 23.2 was used for data analysis. Frequency and percentage was calculated for categorical variables like Hirsutism, Hyperandrogenism mean and standard deviation was calculated for quantitative variables like age, BMI, Height , weight, serum levels of FSH, LH, And testosterone. T test was applied to check the statistical significance. Effect modifiers and confounders like age, height, weight and BMI were controlled by stratification of data. Post stratification CHI square test was used to check effect modification. P value 8). Among 34 patients with Hyperandrogenism, 57.8% (n=20) had Hirsutism and out of 46 patients without Hyperandrogenism 60.7% (n=28) had Hirsutism; this difference was not statistically significant; p=0.685. Conclusion: The observations of our study concluded that a significant numbers of patients with PCOS had Hyperandrogenism and there was no difference in the number of patients with Hirsutism between hyper androgenic and non-hyper androgenic PCOS patients.
Publication Details
Page(s) 112-117
DOI DOI not available
Published Journal: Journal of Islamic International Medical College, Volume: 13, Issue: 3, Year: 2018

Request the full text from PASTIC

References
GoodmanNF,CobinRH,FutterweitW,GlueckJS,LegroRS,EndoPract, 2015.C a r m i n a E . A m e r i c a n A s s o c i a t i o n o f C l i n i c a l Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 1, 21 1291 -300
PasqualiR,ZanottiL,FanelliF,MezzulloM,FazziniA,Morselli Labate, .Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective,J Clin Endo & Metabol 20161 2013 -22
GoodmanNF,CobinRH,FutterweitW,GlueckJS,LegroRS,EndoPract, 2015.C a r m i n a E . A m e r i c a n A s s o c i a t i o n o f C l i n i c a l Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome-part 2, 21 1415 -26
LegroRS,ArslanianSA,EhrmannDA,HoegerKM,MuradMH,PasqualiR, .Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline,J Clin Endo & Metabol 20131 4565 -92
MenonM,RamachandranV, .Antithyroid peroxidase antibodies in women with polycystic ovary syndrome,J Obstet and Gynecol India 20171 61 -5
PalombaS,De WildeMA,FalboA,KosterMP,La SalaGB,FauserBC, .Pregnancy complications in women with polycystic ovary syndrome,Hum repro update. 201527;21 575 -92
ForoozanfardF,TalebiM,SamimiM,MehrabiS,BadehnooshB,JamilianM, 2017.Effect of two different doses of vitamin D supplementation on metabolic profiles of insulin-resistant patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial,Horm and Metabol Rese 49 612 -7
CaldwellAS,MiddletonLJ,JimenezM,DesaiR,McMahonAC,AllanCM, .Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models,Endocrinol 20141 3146 -59
SadrzadehS,PainterRC,LambalkCB, .Developmental origins of polycystic ovary syndrome (PCOS), a case control study comparing birth weight in women with PCOS and control group,Gynecol Endocrinol 20162 856 -9
LivadasS,PappasC,KarachaliosA,MarinakisE,ToliaN,DrakouM, 2014.Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome,Endo 47 631 -8
ConwayG,DewaillyD,Diamanti-KandarakisE., 2015.The polycystic ovary syndrome. A position statement from the European Society of Endocrinology,Repro Endocrinol 25 32 -52
PinolaP,PuukkaK,PiltonenTT,PuurunenJ,VankyE,Sundström-PoromaaI, 2017.Normo-and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life,Fertil and steril 107 788 -95
MoranC,ArriagaM,Arechavaleta-VelascoF,MoranS., 2015.Adrenal androgen excess and body mass index in polycystic ovary syndrome,J Clin Endocrinol & Metabol 100 942 -50
EzehU,YildizBO,AzzizR, 2013.Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome,J Clin Endocrinol & Metabol 98 1088 -96
JohamAE,TeedeHJ,RanasinhaS,ZoungasS,BoyleJ, 2015.Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study,J women's health 24 299 -307
PorcaroG,BizzarriM,MonastraG,FilatiP,UnferV, 2016.Strategies for the treatment of polycystic ovary syndrome (PCOS) women: the role of myoinositol (MI) and d-chiroinositol (DCI) between diet and therapy. Polycystic ovary syndrome (PCOS): clinical aspects, potential complications and dietary management, -
ClarkNM,PodolskiAJ,BrooksED,ChizenDR,PiersonRA,LehotayDC, 2014.Prevalence of polycystic ovary syndrome phenotypes using updated criteria for polycystic ovarian morphology: an assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome,Repro Sci 21 1034 -43
KelleyCE,BrownAJ,DiehlAM,SetjiTL, 2014.Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome,World J Gastroenterol 20 14172 -
0

Citations

0

Downloads

96

Views